Author(s): Rolfs, Prof. Arndt, MD, Niemann, Markus, MD, Störk, Stefan, MD PhD, Bijnens, Bart, PhD, Breunig, Frank, MD, Beer, Prof. Meinrad, MD, Ertl, Georg, MD, Wanner, Christoph, MD
In this publication our data show that the biomarker lyso-Gb3 may identify the clinically relevant agalA mutations leading to Fabry disease. Read more!
Our data show that the biomarker lyso-Gb3 may identify the clinically relevant agalA mutations leading to Fabry disease.
Read publication (PDF)
